Research Article

An Open-Label Exploratory Clinical Trial Evaluating the Effects of GLS (Coptidis Rhizoma-Evodiae Fructus 2 : 1) on Fibroblast Growth Factor 21 in Patients with Nonalcoholic Fatty Liver Disease

Table 2

Comparison of baseline characteristics and parameters changes after treatment.

VariablesGLS (n = 59)PPC (n = 60)F value
BaselineEndChangeBaselineEndChange

Weight (kg)71.04 ± 6.1767.59 ± 6.433.45 ± 2.2269.31 ± 7.1767.36 ± 7.031.95 ± 1.1020.2260.000
Waist circumference (cm)84.34 ± 4.7377.41 ± 5.066.93 ± 2.5883.98 ± 5.3280.06 ± 5.263.92 ± 1.6258.2650.000
Body mass index (kg/m2)26.70 ± 1.0425.17 ± 1.121.54 ± 0.8426.42 ± 1.0125.68 ± 1.060.74 ± 0.4239.7250.000
Waist-to-hip ratio0.88 ± 0.050.81 ± 0.060.07 ± 0.030.88 ± 0.540.84 ± 0.540.04 ± 0.0257.2310.000
Controlled attenuation parameters (db/m)271.51 ± 27.89235.88 ± 28.6635.63 ± 19.70270.48 ± 24.06249.70 ± 20.3220.78 ± 17.7821.5740.000
Fibroblast growth factor 21 (pg/mL)130.80 ± 28.2998.82 ± 17.6431.97 ± 32.69135.02 ± 32.12111.49 ± 21.6523.53 ± 39.3412.0730.001
Alanine transaminase (U/L)73.51 ± 28.6534.10 ± 10.7639.41 ± 23.7973.13 ± 31.4143.17 ± 15.4130.02 ± 24.0423.3730.000
Aspartate transaminase (U/L)53.10 ± 18.8830.66 ± 10.8922.44 ± 16.5055.07 ± 20.9535.98 ± 12.2319.08 ± 15.867.2240.008
Gamma-glutamyl transferase (U/L)75.39 ± 21.6343.66 ± 15.4531.73 ± 15.9974.72 ± 22.7553.20 ± 18.0821.52 ± 17.8317.7520.000
Triglyceride (mmol/L)3.23 ± 0.761.86 ± 0.351.37 ± 0.673.11 ± 0.942.10 ± 0.471.01 ± 0.767.6590.007
Total cholesterol (mmol/L)5.28 ± 0.314.85 ± 0.440.43 ± 0.335.25 ± 0.315.04 ± 0.490.21 ± 0.482.8330.005
High-density lipoprotein cholesterol (mmol/L)1.07 ± 0.301.25 ± 0.28−0.18 ± 0.181.01 ± 0.281.17 ± 0.25−0.16 ± 0.160.5600.456
Low-density lipoprotein cholesterol (mmol/L)3.11 ± 0.452.79 ± 0.410.31 ± 0.353.08 ± 0.312.96 ± 0.290.12 ± 0.1320.5410.000
Glucose (mmol/L)6.24 ± 0.604.89 ± 0.111.35 ± 0.636.21 ± 0.705.53 ± 0.820.68 ± 0.7130.8740.000

All the values are expressed as the mean ± SD. The values compare the parameters changes between the two groups.